1.7M
XNAS Volume
High volume today
XNAS 18 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Wladimir Hogenhuis | Director | Purchase of securities on an exchange or from another person at price $ 4.70 per share. | 16 Feb 2025 | 10,000 | 77,267 | - | 4.7 | 47,000 | Common Shares |
| Daron Evans | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 77,000 | 227,900 | - | 0 | Common Shares | |
| Daron Evans | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 45,000 | 45,000 | - | - | Employee Stock Option (Right to Buy) | |
| Gil M. Labrucherie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 15,000 | 15,000 | - | - | Director Stock Option (Right to Buy) | |
| Gil M. Labrucherie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 25,500 | 25,500 | - | 0 | Common Shares | |
| Nevan Charles Elam | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 120,000 | 120,000 | - | - | Employee Stock Option (Right to Buy) | |
| Nevan Charles Elam | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 204,000 | 211,817 | - | 0 | Common Shares | |
| Philippe Fauchet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 25,500 | 25,500 | - | 0 | Common Shares | |
| Philippe Fauchet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 15,000 | 15,000 | - | - | Director Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 15,000 | 15,000 | - | - | Director Stock Option (Right to Buy) | |
| Nerissa C. Kreher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 25,500 | 25,500 | - | 0 | Common Shares | |
| Brian Kenneth Roberts | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 45,000 | 45,000 | - | - | Employee Stock Option (Right to Buy) | |
| Brian Kenneth Roberts | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 77,000 | 131,352 | - | 0 | Common Shares | |
| Wladimir Hogenhuis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 15,000 | 15,000 | - | - | Director Stock Option (Right to Buy) | |
| Wladimir Hogenhuis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 25,500 | 67,267 | - | 0 | Common Shares | |
| Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 4.29 per share. | 18 Dec 2024 | 10,000 | 150,900 | - | 4.3 | 42,900 | Common Shares |
| Evans Daron | CFO | Purchase of securities on an exchange or from another person at price $ 4.60 per share. | 12 Dec 2024 | 9,000 | 140,900 | - | 4.6 | 41,400 | Common Shares |
| Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 5.04 per share. | 09 Dec 2024 | 10,549 | 131,900 | - | 5.0 | 53,167 | Common Shares |
| Wladimir Hogenhuis | Director | Purchase of securities on an exchange or from another person at price $ 4.70 per share. | 24 Sep 2024 | 4,259 | 41,767 | - | 4.7 | 20,017 | Common Stock |
| Daron Evans | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2024 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Young-jin Kim | Director | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 25 Jun 2024 | 1,250,000 | 7,192,617 | - | 4 | 5,000,000 | Common Shares |
| Young-jin Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 15,000 | 15,000 | - | - | Director Stock Option (Right to Buy) | |
| Wladimir Hogenhuis | Director | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 25 Jun 2024 | 4,815 | 37,508 | - | 4.1 | 19,982 | Common Stock |
| Young-jin Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 25,500 | 140,950 | - | 0 | Common Shares | |
| Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.91 per share. | 14 Jun 2024 | 3,000 | 13,000 | - | 3.9 | 11,725 | Common Shares |
| Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.97 per share. | 14 Jun 2024 | 300 | 1,376 | - | 4.0 | 1,191 | Common Shares |
| Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.91 per share. | 14 Jun 2024 | 4,000 | 54,052 | - | 3.9 | 15,640 | Common Shares |
| Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.96 per share. | 14 Jun 2024 | 300 | 54,352 | - | 4.0 | 1,188 | Common Shares |
| Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 4.04 per share. | 14 Jun 2024 | 40,000 | 40,000 | - | 4.0 | 161,568 | Common Shares |
| Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 29 May 2024 | 451 | 121,351 | - | 3.5 | 1,579 | Common Shares |
| Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 2.84 per share. | 23 May 2024 | 58 | 10,058 | - | 2.8 | 165 | Common Shares |
| Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 3.23 per share. | 23 May 2024 | 2,942 | 13,000 | - | 3.2 | 9,503 | Common Shares |
| Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.68 per share. | 23 May 2024 | 6,000 | 50,052 | - | 2.7 | 16,058 | Common Shares |
| Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.72 per share. | 23 May 2024 | 1,500 | 44,052 | - | 2.7 | 4,080 | Common Shares |
| Kenneth Brian Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.55 per share. | 28 Mar 2024 | 500 | 1,076 | - | 2.6 | 1,275 | Common Shares |
| Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 15 Mar 2024 | 20,000 | 20,000 | - | 1.7 | 33,830 | Common Shares |
| Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.88 per share. | 14 Mar 2024 | 10,000 | 10,000 | - | 1.9 | 18,800 | Common Shares |
| Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 1.93 per share. | 08 Mar 2024 | 50,000 | 120,900 | - | 1.9 | 96,345 | Common Shares |
| Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 07 Mar 2024 | 500 | 576 | - | 1.9 | 925 | Common Shares |
| Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 07 Mar 2024 | 500 | 500 | - | 1.9 | 925 | Common Shares |
| Nevan Charles Elam | Director, CEO | Purchase of securities on an exchange or from another person at price $ 1.68 per share. | 26 Feb 2024 | 5,000 | 7,817 | - | 1.7 | 8,400 | Common Shares |
| Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.70 per share. | 23 Feb 2024 | 2,000 | 42,552 | - | 1.7 | 3,400 | Common Shares |
| Roberts Brian Kenneth | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 23 Feb 2024 | 6,000 | 40,552 | - | 1.7 | 10,140 | Common Shares |
| Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 16 Feb 2024 | 4,500 | 4,500 | - | 1.4 | 6,165 | Common Shares |
| Kenneth Roberts Brian | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.31 per share. | 16 Feb 2024 | 7,000 | 34,552 | - | 1.3 | 9,142 | Common Shares |
| Evans Daron | CFO | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 16 Feb 2024 | 4,500 | 4,500 | - | 1.4 | 6,165 | Common Shares |
| Evans Daron | CFO | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 16 Feb 2024 | 41,900 | 70,900 | - | 1.3 | 54,411 | Common Shares |
| Kreher C. Nerissa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 30,000 | 30,000 | - | - | Director Stock Options (Right to Buy) | |
| M. Gil Labrucherie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 30,000 | 30,000 | - | - | Director Stock Option (Right to Buy) | |
| Evans Daron | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 275,000 | 275,000 | - | - | Employee Stock Option (Right to Buy) | |
| Brian Roberts Kenneth | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 130,000 | 130,000 | - | - | Employee Stock Option (Right to Buy) | |
| Wladimir Hogenhuis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 30,000 | 30,000 | - | - | Director Stock Option (Right to Buy) | |
| Fauchet Philippe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 30,000 | 30,000 | - | - | Director Stock Option (Right to Buy) | |
| Elam Charles Nevan | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 340,000 | 340,000 | - | - | Employee Stock Options (Right to Buy) | |
| Brian Kenneth Roberts | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 03 Jul 2023 | 5,000 | 27,552 | - | 1.9 | 9,500 | Common Shares |
| Young-jin Kim | Director | Purchase of securities on an exchange or from another person at price $ 3.80 per share. | 22 Jul 2022 | 78,947 | 78,947 | - | 3.8 | 299,999 | Common Shares |
| Young-jin Kim | Director | Purchase of securities on an exchange or from another person at price $ 1.91 per share. | 22 Jul 2022 | 36,503 | 115,450 | - | 1.9 | 69,859 | Common Shares |
| Gil M. Labrucherie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Nevan C. Elam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 2,600,000 | 2,600,000 | - | - | Stock Option (right to buy) | |
| Young-jin Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Brian Kenneth Roberts | Sr VP, Clinic Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 700,000 | 700,000 | - | - | Stock Option (right to buy) | |
| Wladimir Hogenhuis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Nerissa C. Kreher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Philippe Fauchet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Brian Kenneth Roberts | Sr VP, Clinic Development | Purchase of securities on an exchange or from another person at price $ 3.41 per share. | 17 May 2022 | 1,000 | 22,052 | - | 3.4 | 3,407 | Common Stock |
| Brian Kenneth Roberts | Sr VP, Clinic Development | Purchase of securities on an exchange or from another person at price $ 2.86 per share. | 17 May 2022 | 200 | 22,252 | - | 2.9 | 572 | Common Stock |
| Brian Kenneth Roberts | Sr VP, Clinic Development | Purchase of securities on an exchange or from another person at price $ 2.95 per share. | 17 May 2022 | 300 | 22,552 | - | 2.9 | 884 | Common Stock |
| Brian Kenneth Roberts | Sr VP, Clinic Development | Purchase of securities on an exchange or from another person at price $ 3.80 per share. | 04 May 2022 | 21,052 | 21,052 | - | 3.8 | 79,998 | Common Stock |
| Gil M. Labrucherie | Director | Purchase of securities on an exchange or from another person at price $ 3.80 per share. | 04 May 2022 | 52,631 | 53,572 | - | 3.8 | 199,998 | Common Stock |
| Wladimir Hogenhuis | Director | Purchase of securities on an exchange or from another person at price $ 3.80 per share. | 15 Oct 2021 | 25,000 | 32,693 | - | 3.8 | 95,000 | Common Stock |
| Wladimir Hogenhuis | Director | Purchase of securities on an exchange or from another person at price $ 6.50 per share. | 15 Oct 2021 | 7,693 | 7,693 | - | 6.5 | 50,005 | Common Stock |
| Brian Kenneth Roberts | Sr VP, Clinic Development | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jun 2021 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Nevan C. Elam | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jun 2021 | 34,800 | 0 | - | - | Stock Option (right to buy) | |
| Gil M. Labrucherie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Nevan C. Elam | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jun 2021 | 100,000 | 575,000 | - | - | Stock Option (right to buy) | |
| Nevan C. Elam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 375,000 | 675,000 | - | - | Stock Option (right to buy) | |
| Nevan C. Elam | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jun 2021 | 70,000 | 0 | - | - | Stock Option (right to buy) | |
| Nerissa C. Kreher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Wladimir Hogenhuis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Brian Kenneth Roberts | Sr VP, Clinic Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Brian Kenneth Roberts | Sr VP, Clinic Development | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jun 2021 | 9,000 | 0 | - | - | Stock Option (right to buy) | |
| Philippe Fauchet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 2,000 | 2,000 | - | - | Stock Option (right to buy) | |
| Sankaram Mantripragada | Chief Scientific Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Apr 2014 | 500,000 | 1,500,000 | - | - | Stock Option (right to buy) | |
| Nevan C. Elam | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2014 | 1,350,000 | 4,850,000 | - | - | Stock Option (right to buy) | |
| Hoyoung Huh | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2014 | 350,000 | 2,850,000 | - | - | Stock Option (right to buy) | |
| Steve R. Howe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2014 | 125,000 | 1,125,000 | - | - | Stock Option (right to buy) | |
| Nevan C. Elam | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 26 Mar 2014 | 234,700 | 234,700 | - | - | Warrant to purchase common stock | |
| Nevan C. Elam | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2014 | 1,057,693 | 5,057,693 | - | - | Common Stock | |
| Hoyoung Huh | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 26 Mar 2014 | 234,700 | 234,700 | - | - | Warrant to purchase common stock | |
| Hoyoung Huh | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2014 | 1,057,693 | 5,057,693 | - | - | Common Stock | |
| Steve R. Howe | None | Other type of transaction at price $ 0.00 per share. | 17 Apr 2013 | 1,000,000 | 1,000,000 | - | - | Option to purchase Common Stock | |
| Orit Wolkin | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Sep 2012 | 893,750 | 0 | - | - | Shares of Common Stock | |
| Guy Turnowski | Director, Secretary | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Sep 2012 | 10,000 | 0 | - | - | Shares of Common Stock | |
| Nir Bar | Director, President and Treasurer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Sep 2012 | 490,000 | 0 | - | - | Shares of Common Stock | |
| Nir Bar | Director, President and Treasurer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Sep 2012 | 43,750 | 0 | - | - | Shares of Common Stock | |
| Chu Min Jue | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Sep 2012 | 893,750 | 0 | - | - | Shares of Common Stock | |
| Nir Bar | Director, President and Treasurer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Jun 2012 | 43,750 | 43,750 | - | - | Shares of Common Stock | |
| Chu Min Jue | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Jun 2012 | 43,750 | 893,750 | - | - | Shares of Common Stock | |
| Orit Wolkin | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Jun 2012 | 43,750 | 893,750 | - | - | Shares of Common Stock |